Rizhao Kanghui Bio-pharmaceutical Technology Co., Ltd (Kanghui-Bio), with synthetic biology as the foundation and innovative research and development as the driving force, is committed to the research and development of multi-dimensionally integrated biopharmaceuticals of ‘peptide, nano-antibody and enzyme substitution therapeutics’ as well as the promotion of industrialization. At present, we have established three major technology platforms: ‘Bio-based Peptide Synthesis Platform’, ‘Leading Nanobody Discovery Technology Platform’ and ‘Perfect Recombinant Protein Preparation Technology Platform’.